Clinical evaluation of the efficacy and safety of Hochuekkito for fatigue in patients with myeloproliferative neoplasms
Not Applicable
- Conditions
- myeloproliferative neoplasms
- Registration Number
- JPRN-UMIN000031519
- Lead Sponsor
- Department of Hematology, Juntendo University School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 110
Inclusion Criteria
Not provided
Exclusion Criteria
1.Severe complications including liver disease and respiratory disease 2.Alergy to chinese traditional medicine 3.Treated with other chinese traditional medicine within 2 weeks. 4.Participated to other clinical trials 5.Determined as inappropriate by the researcher
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method MPN-SAF TSS at week 8
- Secondary Outcome Measures
Name Time Method